Alnylam Pharmaceuticals, Inc. (FRA:DUL)

Alnylam Pharmaceuticals Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 18, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	45,124	29,316	21,731	27,358	17,834	12,344
Market Cap Growth	44.64%	34.90%	-20.57%	53.40%	44.47%	7.89%
Enterprise Value	45,166	29,263	21,965	27,663	17,475	11,967
Last Close Price	340.80	225.80	175.80	221.35	149.40	105.76
PS Ratio	16.49	13.50	13.14	28.18	24.02	30.64
PB Ratio	226.36	452.40	-108.87	-184.79	34.48	14.86
P/TBV Ratio	226.36	452.40	-	-	34.48	14.86
P/FCF Ratio	239.17	-	572.67	-	-	-
P/OCF Ratio	199.14	-	230.62	-	-	-
EV/Sales Ratio	16.49	13.48	13.28	28.50	23.54	29.70
EV/FCF Ratio	239.39	-	578.81	-	-	-
Debt / Equity Ratio	11.86	40.89	-12.16	-16.51	3.72	1.57
Debt / FCF Ratio	12.53	-	63.96	-	-	-
Asset Turnover	0.71	0.56	0.50	0.29	0.24	0.17
Inventory Turnover	6.83	3.86	2.85	1.57	1.74	1.19
Quick Ratio	2.37	2.61	2.86	3.17	3.79	4.23
Current Ratio	2.54	2.78	3.08	3.51	4.04	4.47
Return on Equity (ROE)	32.73%	-	-	-526.14%	-106.31%	-69.92%
Return on Assets (ROA)	3.65%	-2.74%	-4.78%	-13.65%	-12.56%	-17.85%
Return on Capital (ROIC)	5.74%	-4.19%	-7.17%	-18.77%	-16.46%	-23.80%
Return on Capital Employed (ROCE)	8.00%	-5.80%	-9.90%	-28.30%	-24.00%	-29.40%
Earnings Yield	0.08%	-0.92%	-1.83%	-3.87%	-4.21%	-5.68%
FCF Yield	0.42%	-0.14%	0.18%	-2.10%	-3.54%	-4.54%
Buyback Yield / Dilution	-4.82%	-2.20%	-2.64%	-2.73%	-3.01%	-5.24%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.